Pharmafile Logo
Pharmafocus logo
Advanced Search

NICE

Showing 15 posts of 866 posts found.

Yervoy image

NICE recommends Yervoy

June 13, 2014
Sales and Marketing BMS, Cancer, Dillon, NHS, NICE, Yervoy, melanoma

Bristol-Myers Squibb has received a lift from the UK’s drugs watchdog, which has recommended its vaccine Yervoy as a first-line …

News
Statins image

Researchers question ‘bias’ NICE on statins

June 11, 2014
Sales and Marketing Drug pricing, Haslam, NHS, NICE, statins

Doctors are warning that NICE’s desire to increase prescriptions of statins in England is based on pharma-funded research that ignores …

News
Haslam image

David Haslam: NICE, drug pricing and ethics

June 2, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Chairman, Dillon, NHS, NICE, adams, has lam

Since 2010, I have spent a great deal of time of writing about NICE, covering nearly all of all its …

Feature
Zytiga image

NICE: no early Zytiga use

May 14, 2014
Sales and Marketing Cancer, Janssen, NHS, NICE, Zytiga, johnson, prostate

Janssen has criticised NICE’s decision not to recommend Zytiga on the NHS at an earlier stage in the prostate cancer …

News

NICE recommends Xtandi

May 9, 2014
Sales and Marketing Astellas, NICE, Xtandi, abiraterone, prostate

NICE has reiterated that Astellas Pharma’s Xtandi should be used to treat NHS prostate cancer patients – but has removed …

News

US cancer docs warn of rising drug prices

May 7, 2014
Research and Development, Sales and Marketing ASCO, Cancer, NICE, Obama, US, United States, republicans

American cancer doctors are warning that the rising price of oncology medicines is making it unaffordable for the country’s healthcare …

News
Haslam image

NICE chair: pharma must show how it prices drugs

April 28, 2014
Research and Development, Sales and Marketing Goldacre, Haslam, NICE, VBP, all trials, pars

The pharmaceutical industry must be willing to show the public how it prices its drugs – or face losing its …

News
kadcyla image

NICE rejects Kadcyla

April 23, 2014
Sales and Marketing CDF, Cancer, Genentech, Kadcyla, NHS, NICE, Roche

NICE has delivered a severe blow to Roche by rejecting its breast cancer ‘smart bomb’ Kadcyla for NHS use in …

News
abpi_reception

NHS needs to understand drug costs better, says ABPI

April 10, 2014
Medical Communications, Research and Development, Sales and Marketing ABPI, AGNSS, Deepak Khanna, NICE, Stephen Whitehead, Tarceva, soliris

The UK healthcare system is at risk of failing to adopt new, personalised medicines and must be willing to pay …

News
tarceva_roche_2

NICE U-turn on Roche cancer drug

April 4, 2014
Medical Communications, Sales and Marketing NICE, Roche, Tarceva, U-turn

Roche’s lung cancer drug Tarceva has been given a reprieve to treat relapsed lung cancer patients in the NHS after …

News
Stelara image

Stelara hit by final NICE rejection

March 28, 2014
Sales and Marketing Janssen, NICE, UK, arthritis, psoriatic, stelar

In final draft guidance released today NICE says it cannot recommend Janssen’s psoriatic arthritis drug Stelara. Specifically, the pricing watchdog …

News
NICE image

NICE launches VBA consultation

March 27, 2014
Sales and Marketing Dillon, England, NHS, NICE, VBP, catchpole, pars, vba

NICE has today launched its consultation into how value-based assessment of drugs will work in practice, which will run for …

News
Xalkori image

Pfizer’s Xalkori impresses in new setting

March 26, 2014
Research and Development, Sales and Marketing NHS, NICE, NSCLC, Pfizer, Xalkori, lung cancer

Pfizer’s lung cancer treatment Xalkori has proven better at treating patients in a first-line setting when compared to chemotherapy. This …

News
sanofi

Final no for Sanofi’s Zaltrap

March 25, 2014
Medical Communications, Sales and Marketing NICE, Sanofi, Zaltrap, colorectal cancer

News
xofigo_bayer

NICE says ‘no’ to Xofigo

March 24, 2014
Sales and Marketing Bayer, CDF, NHS, NICE, abiraterone, prostate, xofigo

NICE has dealt Bayer a severe blow by not approving prostate cancer drug Xofigo for use on the NHS in …

News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026